Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine

By Liangbiao H.   Ngichabe C.   Trimarchi C.V.   Esposito J.J.   Scott F.W.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1466-1472

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a recombinant lumpy skin disease virus (neethling vaccine strain) expressing the rabies virus glycoprotein in cattle

By Aspden K.   Dijk A.A.v.   Bingham J.   Cox D.   Passmore J.-A.   Williamson A.-L.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2693-2701

Elsevier

Access to resources Recommend Favorite

Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine

By Jones R.L.   Froeschle J.E.   Atmar R.L.   Matthews J.S.   Sanders R.   Pardalos J.   Moeller L.   Chin J.E.   Famula M.   Briggs D.J.   Lang J.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4635-4643

Elsevier

Access to resources Recommend Favorite

Preclinical evaluation of an ALVAC (canarypox)-human cytomegalovirus glycoprotein B vaccine candidate

By Gonczol E.   Berencsi K.   Pincus S.   Endresz V.   Meric C.   Paoletti E.   Plotkin S.A.  

Vaccine, Vol. 13, Iss. 12, 1995-08 ,pp. : 1080-1085

Elsevier

Access to resources Recommend Favorite

Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species

By Taylor J.   Meignier B.   Tartaglia J.   Languet B.   VanderHoeven J.   Franchini G.   Trimarchi C.   Paoletti E.  

Vaccine, Vol. 13, Iss. 6, 1995-04 ,pp. : 539-549

Elsevier

Access to resources Recommend Favorite